ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 208 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$779,000
+1342.6%
159,002
+1121.3%
0.00%
Q2 2022$54,000
-96.5%
13,019
-86.8%
0.00%
-100.0%
Q4 2020$1,539,000
-4.2%
98,603
-42.0%
0.00%
-33.3%
Q3 2020$1,606,000
+154.1%
169,900
+140.8%
0.00%
+200.0%
Q2 2020$632,000
+38.3%
70,569
-1.7%
0.00%0.0%
Q1 2020$457,000
-89.7%
71,800
-69.3%
0.00%
-90.0%
Q1 2018$4,447,000234,0640.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders